Detalhe da pesquisa
1.
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020.
Int J Cancer
; 152(12): 2474-2484, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779785
2.
Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature.
BMC Cancer
; 22(1): 381, 2022 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397511
3.
Assessing the magnitude of changes from protocol to publication-a survey on Cochrane and non-Cochrane Systematic Reviews.
PeerJ
; 11: e16016, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37810785
4.
Meta-research studies should improve and evaluate their own data sharing practices.
J Clin Epidemiol
; 149: 183-189, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35623542
5.
Pharmacology and pharmacovigilance of protein kinase inhibitors.
Therapie
; 77(2): 207-217, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34895753
6.
Intent to share Annals of Internal Medicine's trial data was not associated with data re-use.
J Clin Epidemiol
; 137: 241-249, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33915263
7.
Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations.
BMJ Open
; 10(5): e038887, 2020 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474433